Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second Generation Surveillance Techniques to Prevent Thrombosis and Increase Assisted Primary Patency in Native Arteriovenous Fistula. A Prospective Controlled Trial.

NCT02111655 is registered in ClinicalTrials.gov with Hospital Infanta Sofia as lead sponsor.

NCT NCT02111655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02111655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second Generation Surveillance Techniques to Prevent Thrombosis and Increase Assisted Primary Patency in Native Arteriovenous Fistula. A Prospective Controlled Trial.
Lead sponsor
Hospital Infanta Sofia
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2012
Completion date
September 29, 2015
Enrollment
212 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

thrombosis